Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: Shigru Kwatha: 20 ml BD for 3 months
Intervention2: Gokshura Churna: 3gm BD for 3 months
Intervention3: Shigru Kwatha and Gokshura Churna: Kwatha- 20 ml BD and Churna- 3 gm BD for 3 mon
Sponsors
Ayurvedic and Unani Tibbia College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects willing to participate and able to provide written informed consent. 2. Subjects belonging to either gender between the age group 20 to 60 years. 3. Patient diagnosed as Stage- 1 E.H.T. would be selected for study on the basis of 7th JNC & WHO criteria. 4. Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plan.
Exclusion criteria
Exclusion criteria: 1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease / Renal disease/ Hypertensive Retinopathy. 2. Subjects with any unstable Heart disease or known cases of MI, unstable angina or CHF. 3. Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction, uncontrolled Pulmonary Dysfunction (asthmatic and COPD subjects). 4. Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in last five years). 5. Subjects who have a recent history or who are currently known to abuse of alcohol or drugs. 6. Subjects suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, TB, AIDS etc). 7. Female subject of child bearing potential who do not agree to remain abstinent or use medically acceptable methods of contraception during the study therapy and for 4 weeks after the end of study therapy. 8. Pregnant / Lactating women. 9. Subject on systemic or oral steroids, oral contraceptive pills or estrogen replacement therapy. 10. Subjects having hypersensitivity to any of the trial drug. 11. Subjects who have completed participation in any other clinical trial during the past six (06) months. 12. Pregnancy induced hypertension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Subjective SymptomsTimepoint: Follow up at 15 days interval | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Blood Pressure readingsTimepoint: Follow up at 15 days interval | — |
Countries
India
Contacts
Public ContactDr Shikha
Ayurvedic and Unani Tibbia College and Hospital
Outcome results
None listed